State Street’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.42K | Hold |
15,765
| – | – | ﹤0.01% | 4253 |
|
|
2025
Q4 | $9.14K | Hold |
15,765
| – | – | ﹤0.01% | 4271 |
|
|
2025
Q3 | $5.28K | Hold |
15,765
| – | – | ﹤0.01% | 4276 |
|
|
2025
Q2 | $26K | Hold |
15,765
| – | – | ﹤0.01% | 4179 |
|
|
2025
Q1 | $24.9K | Hold |
15,765
| – | – | ﹤0.01% | 4181 |
|
|
2024
Q4 | $52.8K | Hold |
15,765
| – | – | ﹤0.01% | 4102 |
|
|
2024
Q3 | $29.6K | Hold |
15,765
| – | – | ﹤0.01% | 4177 |
|
|
2024
Q2 | $31.1K | Buy |
15,765
+4,100
| +35% | +$10.2K | ﹤0.01% | 4223 |
|
|
2024
Q1 | $35.8K | Hold |
11,665
| – | – | ﹤0.01% | 4210 |
|
|
2023
Q4 | $27.2K | Hold |
11,665
| – | – | ﹤0.01% | 4302 |
|
|
2023
Q3 | $46.7K | Hold |
11,665
| – | – | ﹤0.01% | 4302 |
|
|
2023
Q2 | $47.4K | Hold |
11,665
| – | – | ﹤0.01% | 4431 |
|
|
2023
Q1 | $35.9K | Sell |
11,665
-4
| -0% | -$14 | ﹤0.01% | 4583 |
|
|
2022
Q4 | $31.5K | Hold |
11,669
| – | – | ﹤0.01% | 4659 |
|
|
2022
Q3 | $47K | Hold |
11,669
| – | – | ﹤0.01% | 4670 |
|
|
2022
Q2 | $82K | Buy |
11,669
+344
| +3% | +$2.89K | ﹤0.01% | 4598 |
|
|
2022
Q1 | $133K | Sell |
11,325
-18,898
| -63% | -$225K | ﹤0.01% | 4537 |
|
|
2021
Q4 | $555K | Hold |
30,223
| – | – | ﹤0.01% | 3980 |
|
|
2021
Q3 | $756K | Buy |
30,223
+522
| +2% | +$20.2K | ﹤0.01% | 3850 |
|
|
2021
Q2 | $1.88M | Sell |
29,701
-23,588
| -44% | -$1.87M | ﹤0.01% | 3560 |
|
|
2021
Q1 | $6.57M | Buy |
53,289
+19,679
| +59% | +$2.85M | ﹤0.01% | 2936 |
|
|
2020
Q4 | $3.82M | Buy |
33,610
+6,887
| +26% | +$866K | ﹤0.01% | 3097 |
|
|
2020
Q3 | $3.19M | Buy |
26,723
+6,420
| +32% | +$749K | ﹤0.01% | 3008 |
|
|
2020
Q2 | $2.53M | Buy |
20,303
+10,821
| +114% | +$1.47M | ﹤0.01% | 3085 |
|
|
2020
Q1 | $1.83M | Buy |
9,482
+5,847
| +161% | +$1.83M | ﹤0.01% | 3100 |
|
|
2019
Q4 | $1.21M | Buy |
3,635
+294
| +9% | +$98K | ﹤0.01% | 3370 |
|
|
2019
Q3 | $1.08M | Buy |
3,341
+445
| +15% | +$144K | ﹤0.01% | 3379 |
|
|
2019
Q2 | $1.25M | Buy |
2,896
+1,055
| +57% | +$522K | ﹤0.01% | 3379 |
|
|
2019
Q1 | $1.04M | Sell |
1,841
-707
| -28% | -$339K | ﹤0.01% | 3329 |
|
|
2018
Q4 | $756K | Buy |
2,548
+667
| +35% | +$299K | ﹤0.01% | 3380 |
|
|
2018
Q3 | $1.34M | Buy |
1,881
+580
| +45% | +$358K | ﹤0.01% | 3357 |
|
|
2018
Q2 | $759K | Buy |
1,301
+80
| +7% | +$62.2K | ﹤0.01% | 3431 |
|
|
2018
Q1 | $3.31M | Buy |
+1,221
| New | +$2.97M | ﹤0.01% | 2972 |
|
Other funds holding VYNE
AFM
NCM
LCM
SC
ACM
TC
B
KCA
